Contribution of zinc deficiency to insulin resistance in patients with primary biliary cirrhosis

Biological Trace Element Research

Volumn 144, Issue 1-3, 2011, Pages 133-142

  Himoto, Takashi ^a   Yoneyama, Hirohito ^a   Kurokochi, Kazutaka ^a   Inukai, Michio ^a   Masugata, Hisashi ^a   Goda, Fuminori ^a   Haba, Reiji ^a   Watanabe, Seishiro ^b   Senda, Shoichi ^a   Masaki, Tsutomu ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b KAGAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Copper; Hepatic fibrosis; Insulin resistance; Primary biliary cirrhosis; Zinc

Indexed keywords

COPPER; COPPER PROTEIN; LEPTIN; MITOCHONDRION ANTIBODY; ZINC;

ADULT; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; COPPER BLOOD LEVEL; COPPER METABOLISM; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; PRIMARY BILIARY CIRRHOSIS; THROMBOCYTE COUNT; ZINC BLOOD LEVEL; ZINC DEFICIENCY; ZINC METABOLISM;

ADULT; AGED; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; COPPER; DEUTEROPORPHYRINS; DISEASE PROGRESSION; FEMALE; HEPATITIS C, CHRONIC; HOMEOSTASIS; HUMANS; IMINES; INSULIN RESISTANCE; JAPAN; LEPTIN; LIVER; LIVER CIRRHOSIS; LIVER CIRRHOSIS, BILIARY; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; MITOCHONDRIA, LIVER; PLATELET COUNT; ZINC;

HEPATITIS C VIRUS;

EID: 84155165093     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-011-9049-2     Document Type: Article

References (39)

1. Rubin E, Schaffner F, Popper H (1965) Primary biliary cirrhosis. Am J Pathol 46:387-407
2. Deering TB, Dickson ER, Fleming CR, Gealol MG, McCall JT et al (1977) Effect of d-penicillamine on copper retention in patients with primary biliary cirrhosis. Gastroenterology 72:1208-1212 (Pubitemid 8116684)
3. Vierling JM, Soussi T (1981) Copper metabolism in primary biliary cirrhosis. Semin Liver Dis 1:293-308
4. Vallee BL, Wacker WEC, Bartholomay AF, Robin ED, Vallee RL et al (1956) Zinc metabolism in hepatic dysfunction I. Serum zinc concentration in Laennec's cirrhosis and their validation by sequential analysis. N Eng J Med 255:403-408
5. Goode HF, Kelleher J, Waler BE (1990) Relation between zinc status and hepatic functional reserve in patients with liver disease. Gut 31:694-697 (Pubitemid 20209043)
6. Stamoulis I, Kouraklis G, Theocharis S (2007) Zinc and the liver: an active interaction. Dig Dis Sci 52:1595-1612 (Pubitemid 46870560)
7. Himoto T, Hosomi N, Nakai S, Deguchi A, Kinekawa F et al (2007) Efficacy of zinc administration in patients with hepatitis C virus-related chronic liver disease. Scand J Gastroenterol 42:1078-1087 (Pubitemid 47301142)
8. Himoto T, Yoneyama H, Deguchi A, Kurokohchi K, Inukai M et al (2010) Insulin resistance derived from zinc deficiency in non-diabetic patients with chronic hepatitis C. Exp Ther Med 1:707-711
9. Kinlaw WB, Levine AS, Morley JE, Silvis SE, McClain CJ (1982) Abnormal zinc metabolism in type II diabetes mellitus. Am J Med 75:273-277
10. Chausmer AB (1998) Zinc, insulin and diabetes. J Am Coll Nutr 17:109-115
11. Zargar AH, Shah NA, Masoodi SR, Laway BA, Dar FA et al (1998) Copper, zinc, and magnesium levels in non-insulin dependent diabetes mellitus. Postgrad Med J 74:665-668 (Pubitemid 28508483)
12. Aguilar MV, Saavedra P, Arrieta FJ, Mateos CJ, Gonzalez MJ et al (2007) Plasma mineral content in type 2 diabetic patients and their association with the metabolic syndrome. Ann Nutr Metab 51:402-406 (Pubitemid 350212729)
13. Escarcega RO, Garcia-Carrasco M, Fuentes-Alexandro S et al (2006) Insulin resistance, chronic inflammatory state and the link with systemic lupus erythematosus-related coronary disease. Autoimmun Rev 6:48-53 (Pubitemid 44781092)
14. Chung CP, Oeser A, Solus JF et al (2008) Inflammation-associated insulin resistance. Arthriris Rhuem 58:2105-2112
15. Durazzo M, Niro G, Premoli A et al (2009) Type 1 autoimmune hepatitis and adipokines: new markers for activity and disease progession? J Gastroenterol 44:476-482
16. Longo M, Crosignani A, Battezzati PM et al (2002) Hyperlipidemic state and cardiovascular risk in primary biliary cirrhosis. Gut 51:265-269 (Pubitemid 34791459)
17. Cash WJ, McCance DR, Young IS et al (2010) Primary biliary cirrhosis is associated with oxidative stress and endothelial dysfunction but not increased cardiovascular risk. Hepatol Res 40:1098-1106
18. Degott C, Zafrani ES, Callard P et al (1999) Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histological progression. Hepatology 29:1007-1012 (Pubitemid 29168729)
19. Scheuer PJ (1967) Primary biliary cirrhosis. Proc R Soc Med 60:1257-1260
20. Mattews DR, Hosker JP, Rudenski AS et al (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 28:412-429
21. Jain S, Scheuer J, Archer B et al (1978) Histological demonstration of copper and copper-associated protein in chronic liver disease. J Clin Pathol 31:784-790 (Pubitemid 9010951)
22. Herlong HF, Russell RM, Maddrey WC (1981) Vitamin A and zinc therapy in primary biliary cirrhosis. Hepatology 1:348-351 (Pubitemid 11024429)
23. Hoogenraad TU, Sindram JW (1982) Oral zinc in primary biliary cirrhosis. N Eng J Med 307:122-123 (Pubitemid 12082596)
24. Ritland S, Aaseth J (1987) Trace elements and liver. J Hepatol 5:118-122
25. Stamoulis I, Kouraklis G, Theocharis S (2007) Zinc and the liver: an active interaction. Dig Dis Sci 52:1596-1612
26. Gimenez A, Pares A, Alie S et al (1994) Fibrogenic and collagenolytic activity in carbon-tetrachlorideinjued rats: beneficial effects of zinc administration. J Hepatol 21:292-298 (Pubitemid 24308749)
27. Kivirikko KI, Majamaa K (1985) Synthesis of collagen: chemical regulation of post-translational events. Chiba Found Symp 114:34-64
28. Dodson G, Steiner D (1998) The role of assembly in insulin's biosynthesis. Curr Opin Struct Biol 8:189-194 (Pubitemid 28221050)
29. Salgueiro MJ, Krebs N, Zubillaga MB et al (2001) Zinc and diabetes mellitus Is there a need of zinc supplementation in diabetes mellitus patients? Biol Trace Elem Res 81:215-228 (Pubitemid 32848478)
30. Hui JM, Sud A, Farrell GC et al (2003) Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression. Gastroenterology 125:1695-1704 (Pubitemid 37500434)
31. Fartoux L, Poujol-Robert A, Guechot J et al (2005) Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C. Gut 54:1003-1008 (Pubitemid 40873917)
32. Muzzi A, Leandro G, Rubbia-Brandt L et al (2005) Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients. J Hepatol 42:41-46 (Pubitemid 40038898)
33. Paradis V, Perlemuter G, Bonvoust F et al (2001) High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis. Hepatology 34:738-744 (Pubitemid 32927998)
34. Sipponen P (1976) Orcein positive hepatocellular material in long-standing biliary diseases. Scand J Gastroenterol 11:545-552
35. Vierling JM (1981) Copper metabolism in primary biliary cirrhosis. Semin Liver Dis 1:293-308
36. Hatano R, Ebara M, Fukuda H et al (2000) Accumulation of copper in the liver and hepatic injury in chronic hepatitis C. J Gastroenterol Hepatol 15:786-791 (Pubitemid 30615064)
37. Breidert M, Zimmermann TF, Schneider R et al (2004) Ghrelin/leptin- imbalance in patients with primary biliary cirrhosis. Exp Clin Endocrinol Diabetes 112:123-126 (Pubitemid 38445490)
38. Floreani A, Variola A, Niro G et al (2008) Plasma adoponectin levels in primary biliary cirrhosis: a novel perspective for link between hypercholesterolemia and protection against atherosclerosis. Am J Gastroenterol 103:1959-1965
39. Loria P, Lonardo A, Leonardi F et al (2003) Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates. Dig Dis Sci 48:2173-2181 (Pubitemid 38037305)